Director, Patient Support
Janssen, Pharmaceutical Companies of Johnson & Johnson
Christine MacCracken is Director, Patient Support at the Janssen Pharmaceutical Companies of Johnson and Johnson where she leads strategic identification and implementation of patient-centered initiatives. In this role, she is responsible for the strategic advancement of pre-approval access initiatives such as the Compassionate Use Advisory Committee (CompAC). Her focus is on raising organizational awareness around the patient voice and recognizing “Every Patient is a Person First”.
Christine’s began her career at the Children’s Hospital of Philadelphia where she was an oncology nurse treating families with life changing diagnoses. With these patient experiences front of mind, she developed an interest in research and joined Radiation Therapy Oncology Group (RTOG) focusing on quality of life studies. Bridging this interest with pharmaceutical development, she later joined Merck & Co., Inc. with increasing roles of responsibility in clinical research and academic affairs, ultimately sharing her collective experience as an adjunct professor.
Prior to joining Janssen in 2015, Christine was responsible for Business Insights at the National Comprehensive Cancer Network (NCCN). In support of people with cancer and their providers, she collaborated with industry, state oncology societies and advocacy groups to disseminate NCCN treatment information through health technology platforms as well as market and outcome research programs.
Monday, November 18
2:45 PM – 4:00 PM